Related Experiment Video

Updated: Jun 4, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

Reply to: "A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP-NET"

Ida Wilkens1,2, Sarah Bebermeier3, Stephanie Stiel4

  • 1Department of Neurology, Hannover Medical School, Hannover, Germany.

Movement Disorders : Official Journal of the Movement Disorder Society
|December 19, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
parkinsonismprogressive supranuclear palsyquality of life

More Related Videos

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.7K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

8.7K

Related Experiment Videos

Last Updated: Jun 4, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.7K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

8.7K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216

Articles linked to this work by shared authors, journal, and citation graph.

[Perceived support for autonomy in general practice: a multicenter cross-sectional study].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026

Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome.

Neurology·2026

Long-Term Survival of Borna Disease Virus 1 (BoDV-1)-Encephalitis: An Exceptional Case with Valuable Insights for Pathophysiology and Disease Management.

Infectious diseases and therapy·2026

[Multiple system atrophy].

Fortschritte der Neurologie-Psychiatrie·2026

Multiple system atrophy: cure and care.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Clinical-pharmacological medication reviews for insurants of a German statutory health insurance fund (Kaufmännische Krankenkasse (KKH)): a 5-year retrospective analysis (2019-2023).

Naunyn-Schmiedeberg's archives of pharmacology·2026

Selectivity Filter KCND3 Variant Causes Spinocerebellar Ataxia 19/22 and KV4.3 Functional Loss.

Movement disorders : official journal of the Movement Disorder Society·2026

Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.

Movement disorders : official journal of the Movement Disorder Society·2026

Distinct Spatiotemporal Patterns of Dopaminergic and Metabolic Imaging in De Novo Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Fifteen-Year Outcomes of Bilateral Pallidal Stimulation in Isolated Generalized Dystonia: Characterization of Therapeutic Response and Emergence of Parkinsonism.

Movement disorders : official journal of the Movement Disorder Society·2026

Dopamine-Deficiency-Related Reorganization of the Somatomotor Network in Prodromal and Early Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Culturally adapted post-diagnostic dementia support for South Asian people living with dementia and caregivers: a rapid review.

Age and ageing·2026

Relationship Between EAT-10 Scores, Pharyngeal Residue Severity, and Penetration-Aspiration in Individuals With Idiopathic Parkinson's Disease: A FEES-Based Correlation and Discriminative Performance Study.

International journal of language & communication disorders·2026

Dilated Gallbladder Causing Right Iliac Fossa Pain in a Patient with Advanced Pancreatic Cancer: A Diagnostic and Symptom Management Challenge at End of Life.

Palliative medicine reports·2026

Barriers and Facilitators in Access to Care Among Adults With Traumatic Spinal Cord Injuries: A Qualitative Study Comparing VA and Commercial Insurance.

Health services insights·2026

Sex-related differences in the physical, functional, physiological, and emotional profile of adults with chronic vestibular hypofunction: a cross-sectional EXERVEST study.

Frontiers in rehabilitation sciences·2026

Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury-Induced Secondary Damage by Activating PINK1/Parkin-Mediated Mitophagy and Suppressing ASS1/CPS1-Driven Arginine Biosynthesis.

CNS neuroscience & therapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us